Funding search · The Leona M and Harry B Helmsley · grants
The Leona M and Harry B Helmsley: all 2,251 grants
Largest first · $1.69B across 2021–2024 · back to the overview
- $256,408
The University of Adelaide · 2022
Endia expanded support
- $256,190
Jaeb Center for Health Research Foundation · Tampa, FL · 2022
Virtual diabetes specialty clinic (vdisc) - a study evaluating remote initiation of continuous glucose monitoring
- $256,007
Board of Trustees of the Leland Stanford Junior University · Stanford, CA · 2022
Exercise education at new onset of t1d
- $255,521
Crohn'S and Colitis Canada · 2022
Implementing a multimodal rct intervention to improve the transition of patients with crohns disease from pediatric to adult care
- $254,998
St Mark'S Hospital Foundation · 2024
Support for the ongoing development of the topclass perianal cd consortium
- $254,457
Stichting Pharmaccess International · 2021
Investing in quality healthcare through safecare
- $253,818
The Tel Aviv Jaffa Academic College · 2023
Scholarship support for ultra-orthodox (haredi) men pursuing b.s. Degrees in nursing
- $253,783
Crohn'S and Colitis Canada · 2022
Implementing a multimodal rct intervention to improve the transition of patients with crohns disease from pediatric to adult care
- $253,122
Villages of Hope Africa Society · 2023
Infrastructure improvements and expansion
- $253,075
Lake View Memorial Hospital Foundation of Northeast Minnesota · Two Harbors, MN · 2022
Lake view hospital ultrasound project
- $252,828
Swift County-Benson Hospital · Benson, MN · 2022
Swift county benson hospital ultrasound project
- $251,789
The Chinese University of Hong Kong · 2022
Ibd gives-21: global ibd visualization of epidemiology studies in the 21st century
- $251,607
University of Exeter · 2023
B cell signatures in type 1 diabetes
- $251,522
Genome Research Limited for the Wellcome Sanger Institute · 2023
Scibd-response: massive-scale single-cell rna-sequencing to identify transcriptomic predictors of response to biologic therapies in crohns disease
- $251,447
Massachusetts Institute of Technology · Cambridge, MA · 2023
Computational modeling to improve glucose-responsive glucagon designs
- $250,409
Children'S Hunger Fund · Sylmar, CA · 2021
Medical and orphan care initiative in ethiopia
- $250,000
Genetic Alliance · Damascus, MD · 2024
Ihope genetic health
- $250,000
The Milken Institute · Santa Monica, CA · 2024
Fastercures leaderslink program expansion
- $250,000
Israel Emergency Alliance · Los Angeles, CA · 2023
Support of legal efforts to combat antisemitism, and social media expansion
- $250,000
Mayo Clinic · Rochester, MN · 2023
Military sciences medical training 2022-2024
- $250,000
The Milken Institute · Santa Monica, CA · 2023
Fastercures leaderslink program expansion
- $250,000
Regents of the University of Minnesota · Minneapolis, MN · 2022
Phase 2: engineering antigen-specific regulatory t cells for use in type 1 diabetes
- $250,000
The Milken Institute · Santa Monica, CA · 2022
Fastercures leaderslink program expansion
- $250,000
The Trustees of Columbia University in the City of New York · New York, NY · 2022
Support for t1d transition programs
- $250,000
New York City Health and Hospitals Corporation · New York, NY · 2021
Expresscare platform update and service delivery to homeless patients
- $250,000
Rockefeller Philanthropy Advisors · New York, NY · 2021
Covid collaborative - increasing vaccine uptake in rural america
- $250,000
University of Miami · Coral Gables, FL · 2021
Develop a new method of studying alpha cell function in pancreatic slice
- $250,000
Vanderbilt University Medical Center · Nashville, TN · 2021
Developing an islet model that mimics t1d
- $250,000
Vivli · Cambridge, MA · 2021
Vivli technical debt amelioration
- $250,000
Washington University · St Louis, MO · 2021
Manipulating alpha cell signaling to restore normal glucagon secretory
- $249,913
American Pharmacists Association Foundation · Washington, DC · 2021
Expanding access to cgm through community pharmacy
- $249,897
Herlev Og Gentofte Hospital · 2021
Targeting gip/glp-2 receptors to prevent hypoglycemia in t1d
- $249,337
The Chinese University of Hong Kong · 2023
Ibd gives-21: global ibd visualization of epidemiology studies in the 21st century
- $249,301
Hebrew University of Jerusalem · 2021
Methylation patterns of cell-free dna as a novel biomarker in crohns
- $249,169
Stanford University · Stanford, CA · 2021
Exercise education at new onset of t1d
- $248,621
The Hospital for Sick Children · 2024
Immune responses to gut microbes associated with t1d risk and progression
- $248,597
University of Florida · Gainesville, FL · 2021
T cell receptor sequencing in t1d - biomarker & technology development
- $247,813
University of Exeter · 2024
B cell signatures in type 1 diabetes
- $247,654
The Governors of the University of Calgary · 2023
Quantitative proteomic profiling of fibrostenotic crohns disease patients
- $247,545
University of Cambridge · 2021
Closed loop insulin delivery in newly diagnosed youth with t1d part 2
- $247,023
University of Miami · Coral Gables, FL · 2024
Develop a new method of studying alpha cell function in pancreatic slices
- $246,663
Katholieke Universiteit Leuven · 2022
An enterochromaffin cell and macrophage atlas of the human gut
- $246,662
Katholieke Universiteit Te Leuven · 2023
An enterochromaffin cell and macrophage atlas of the human gut
- $246,267
University of Utah · Salt Lake City, UT · 2021
Anti-phage antibodies: crohns disease diagnosis and treatment response
- $246,186
Universite Catholique De Louvain · 2021
Direct and indirect causes for the impaired glucagon secretion in t1d
- $245,905
Technische Universitaet Muenchen · 2022
Metagenomic pilot project
- $244,998
Adi Negev-Nahalat Eran Ra · 2024
Rehabilitation equipment
- $244,860
Chancellor Masters & Scholars of the University of Oxford · 2024
The cellular landscape of monogenic inflammatory bowel disease in veoibd
- $244,860
Chancellor Masters & Scholars of the University of Oxford · 2023
The cellular landscape of monogenic inflammatory bowel disease in veoibd
- $244,860
The University of Oxford · 2021
The cellular landscape of monogenic inflammatory bowel disease
- $244,200
Vanderbilt University Medical Center · Nashville, TN · 2022
Development of an administrative core and collaborative data repository for the gut cell atlas
- $243,550
Stanford University · Stanford, CA · 2021
Longitudinal study of myoelectric gutprint of crohns patients
- $243,216
Clalit Health Services · 2023
The inflammatory bowel disease mediterranean diet (ibdmed) microbiome-targeting nutritional education program for cd control and prevention
- $243,216
Clalit Health Services · 2022
The inflammatory bowel disease mediterranean diet (ibdmed) microbiome-targeting nutritional education program for cd control and prevention
- $243,196
University of Pittsburgh · Pittsburgh, PA · 2023
Single cell multimodal omics analysis of colonoscopic biopsy-derived immune cells in crohns disease
- $242,153
Clalit Health Services · 2022
The inflammatory bowel disease mediterranean diet (ibdmed) microbiome-targeting nutritional education program for cd control and prevention
- $241,600
Project Nyame Nsa Ltd · Manhasset, NY · 2022
Project nyame nsa zambia expansion
- $241,563
Towner County Medical Center · Cando, ND · 2024
Towner county medical center ultrasound initiative
- $241,490
The Rector and Visitors of the University of Virginia · Charlottesville, VA · 2021
Type 1 diabetes risk prediction: integration of physiology with genetics
- $241,173
The Regents of the University of California San Francisco · San Francisco, CA · 2023
Pregnancy in inflammatory bowel disease and neonatal outcomes (piano)
- $240,907
United Hospital District · Blue Earth, MN · 2022
United hospital district inc. Ultrasound project
- $239,784
Jdrf Australia · 2021
Endia early to mid-career science accelerator awards 2021
- $239,672
The Chinese University of Hong Kong · 2021
Ibd gives-21: global ibd visualization of epidemiology studies, 21st cen
- $239,587
University of Pittsburgh · Pittsburgh, PA · 2022
Single cell multimodal omics analysis of colonoscopic biopsy-derived immune cells in crohns disease
- $239,373
Johns Hopkins University · Baltimore, MD · 2021
A multidisciplinary bioengineering approach to fistula-in-ano in crohns
- $238,556
Mountrail County Medical Center · Stanley, ND · 2024
North dakota ultrasound initiative
- $237,102
University of Pittsburgh · Pittsburgh, PA · 2024
Single cell multimodal omics analysis of colonoscopic biopsy-derived immune cells in crohns disease
- $236,320
University of North Carolina at Chapel Hill · Chapel Hill, NC · 2021
Monitoring covid-19 vaccine effectiveness in ibd patients
- $236,313
The Cleveland Clinic Foundation · Cleveland, OH · 2024
The milestone initiative education innovation for advanced ibd fellows in the usa
- $235,681
The City of Hope · Duarte, CA · 2024
Genetic protection by hla-dq6 in t1d
- $235,507
Children'S Hospital Medical Center · Cincinnati, OH · 2022
Precision crohns disease management utilizing predictive protein panels
- $235,000
Crohn'S & Colitis Foundation · New York, NY · 2024
Sponsorship for the 2025 crohns & colitis congress presented by the crohns & colitis foundation and the american gastroenterological association
- $234,588
Phillips County Hospital Association · Malta, MT · 2022
Tele-emergency and tele-pharmacy at phillips county
- $233,092
Aitkin Community Hospital · Aitkin, MN · 2022
Aitkin community hospital/ riverwood healthcare center ultrasound project
- $232,672
Columbia University · New York, NY · 2021
Combinatorial perturbation of cellular network in crohns disease
- $232,577
Jdrf Australia · 2022
Endia early to mid career science accelerator awards 2021
- $232,068
Helmholtz Zentrum Munchen (Gmbh) · 2022
Fr1da oral insulin intervention trial amendment
- $231,849
Cedars-Sinai Medical Center · Los Angeles, CA · 2022
Integrating genomic and imaging data with scrnaseq to better understand the causes of, and heterogeneity in, crohn's disease
- $231,831
Vanderbilt University · Nashville, TN · 2021
Understanding calcium signaling in alpha cells and how they work in t1d
- $230,038
Academisch Ziekenhuis Leiden · 2023
Safety and efficacy of immune intervention with tolerogenic dendritic cells in patients with early t1d (d-sense ii)
- $230,000
Shatterproof a Nonprofit Corp · Norwalk, CT · 2022
General operating support
- $229,347
Uppsala Universitet · 2023
Alpha-cell signaling for glucagon secretion
- $229,162
Helmholtz Zentrum Munchen (Gmbh) · 2024
Gppad biosample rfp
- $228,012
The Regents of the University of Colorado Denver · Aurora, CO · 2021
Exploring the genomic mechanism behind the maternal protection from t1d
- $227,950
Ideoorg · San Francisco, CA · 2022
Human-centered design study of type 1 diabetes in medically underserved communities in the u.s.
- $227,066
Tampere University Foundation Sr · 2024
Enterovirus-induced type 1 diabetes mechanisms and biomarkers for risk
- $226,169
Regents of the University of Michigan · Ann Arbor, MI · 2024
Health economic analysis of automated insulin delivery systems
- $225,517
Southwest Healthcare Corporation · Bowman, ND · 2024
North dakota ultrasound initiative
- $225,500
Amsterdam Umc Research Bv · 2024
Identification of biomarkers for patient stratification in perianal fistulizing disease
- $224,138
The Regents of the University of Colorado Denver · Aurora, CO · 2021
Complement system in initiation and progression of islet autoimmunity
- $224,000
Tear Australia · 2022
Facilitate secure environments for amplified nutrition
- $223,920
Nevada Department of Health and Human Services · Carson City, NV · 2023
Nevada first responder aed project
- $223,410
Pulitzer Center On Crisis Reporting · Washington, DC · 2021
Building resilience through journalism and education
- $222,500
Action4diabetes · 2024
Philippines t1d task force
- $221,931
Vanderbilt University Medical Center · Nashville, TN · 2023
Screening human islets to identify small molecules enhancing glucagon secretion under hypoglycemia
- $221,552
King'S College London · 2024
Prenatal drivers of infant islet autoimmunity (pisa study)
- $221,500
Hebrew University of Jerusalem · 2024
Methylation patterns of cell-free dna as a novel biomarker in crohns disease
- $221,420
Chancellor Masters & Scholars of the University of Oxford · 2023
Interrogating the mechanism of hypersensitivity to antibody-based drugs for development of a novel anti-tnf biologic for crohns disease
- $221,407
Katholieke Universiteit Te Leuven · 2024
Embody effects of a mindfulness based intervention on ibd disability
- $220,100
Minnesota Rural Health Association · Henning, MN · 2022
Sonographer and technologist training for rural minnesota

